Related Experiment Videos
Adipose tissue function in the insulin-resistance syndrome
1Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford OX3 7LJ, UK. fredrik.karpe@ocdem.ox.ac.uk
Biochemical Society Transactions
|October 26, 2005
Summary
Insulin resistance impairs adipose tissue function, hindering its ability to regulate non-esterified fatty acids (NEFA) and respond to food intake. This dysfunction contributes to the overall insulin-resistance syndrome.
Area of Science:
- Metabolic Syndrome
- Endocrinology
- Adipose Tissue Biology
Background:
- Insulin resistance is closely linked to obesity, with adipose tissue dysfunction playing a key role.
- Non-esterified fatty acids (NEFA) released from expanded adipose tissue interfere with glucose utilization in skeletal muscle, contributing to hyperglycemia.
- Hyperinsulinemia, a hallmark of insulin resistance, may paradoxically inhibit lipolysis in adipose tissue, impairing its normal function.
Purpose of the Study:
- To explore the intricate relationship between adipose tissue function and systemic insulin resistance.
- To elucidate the role of adipose tissue blood flow in the context of insulin resistance.
Main Methods:
- Review of existing literature on adipose tissue function, NEFA metabolism, and insulin resistance.
- Analysis of the impact of hyperinsulinemia on adipose tissue lipolytic activity.
- Examination of adipose tissue blood flow responses in healthy versus insulin-resistant individuals.
Main Results:
- Expanded adipose tissue increases systemic NEFA delivery, promoting insulin resistance in muscle and liver.
- Hyperinsulinemia may lead to constant lipolytic inhibition in adipose tissue, disrupting fat uptake and release.
- Adipose tissue blood flow response to food intake is blunted in insulin-resistant individuals, indicating impaired tissue responsiveness.
Conclusions:
- Adipose tissue dysfunction, including altered NEFA regulation and blunted blood flow responses, is a significant contributor to the insulin-resistance syndrome.
- Understanding these mechanisms is crucial for developing targeted therapies for metabolic disorders.